DAPAVIB 10DAPAGLIFLOZIN 10mg. IP

Dapavib 10 is a Dapagliflozin 10 mg tablet from Vibcare Pharma for type 2 diabetes control and heart failure and kidney risk reduction. Main uses: adjunct to diet and exercise to improve blood sugar control in adults and children aged 10 years and above with type 2 diabetes mellitus; to reduce the risk of sustained eGFR decline, end-stage kidney disease, cardiovascular death and hospitalisation for heart failure in adults with chronic kidney disease at risk of progression; to reduce the risk of cardiovascular death, hospitalisation for heart failure and urgent heart failure visits in adults with heart failure; to reduce the risk of hospitalisation for heart failure in adults with type 2 diabetes mellitus who have established cardiovascular disease or multiple cardiovascular risk factors.

Common side effects of Dapavib 10 Tablet include female genital yeast (mycotic) infections; nasopharyngitis (colds, sore throat); urinary tract infections; increased urination (polyuria); back pain; nausea. Get medical help at once if you notice diabetic ketoacidosis (ketone build-up in the blood); volume depletion with low blood pressure or dizziness; serious genitourinary infections including pyelonephritis and urosepsis.

Each Dapavib 10 tablet contains Dapagliflozin 10 mg. The right dose and how long to take it depend on the condition, age and other medicines, so use Dapavib 10 Tablet only as your doctor advises.

The MRP of Dapavib 10 Tablet is ₹142 for a pack of 5x2x10 (Alu Alu). For chemists and distributors, the PTR is ₹108.19 and the PTS is ₹97.37.

Each Dapavib 10 tablet contains Dapagliflozin 10 mg. It comes in a pack of 5x2x10 (Alu Alu).

Dapagliflozin acts on the proximal tubules of the kidney, where it stops the SGLT2 transporter from reabsorbing filtered glucose. As a result, glucose is excreted in the urine. The same action also decreases sodium reabsorption and raises sodium delivery to the distal tubule, which can lower the heart's pre-load and after-load and reduce the pressure inside the kidney's filtering units.

Must not be used in patients with a history of a serious hypersensitivity reaction (such as anaphylaxis or angioedema) to dapagliflozin or any of its excipients. Check with a doctor first in patients with type 1 diabetes mellitus (not recommended, risk of ketoacidosis). Check with a doctor first in patients with low blood volume, low systolic blood pressure, kidney impairment or those taking diuretics. Check with a doctor first in elderly patients before starting therapy. Check with a doctor first if insulin or an insulin secretagogue is being taken, as low blood sugar may occur.

Dapavib 10 Tablet is a brand of Vibcare Pharma, sold through its Cure division. It is available for PCD pharma franchise and distribution in India; use the Send Enquiry or WhatsApp button on this page to ask about availability and terms.